Evidence map›Paper›PMID 42472721›Full record

ArticleBioresources and bioprocessing2026

Grey-box modeling framework for consolidated bioprocessing systems: an endpoint-guided approach.

Mark Korang Yeboah, Dirk Söffker

Erratum issuedAbstract read
In one paragraph

Article in Bioresources and bioprocessing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Mark Korang YeboahChair of Dynamics and Control, University of Duisburg-Essen, Lotharstraße, 47057, Duisburg, NRW, Germany. mark.korangyeboah@uni-due.de.ORCID http://orcid.org/0009-0006-2131-3147
Dirk SöffkerChair of Dynamics and Control, University of Duisburg-Essen, Lotharstraße, 47057, Duisburg, NRW, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Consolidated bioprocessing (CBP) combines enzyme production, biomass hydrolysis, and fermentation within a single process, but its modeling remains difficult because of biological nonlinearities, feedstock heterogeneity, and limited time-resolved measurements. This paper presents an endpoint-guided grey-box framework that connects data-driven endpoint prediction, phase-structured mechanistic reconstruction, and synthetic state-estimation analysis. A literature-derived CBP ethanol dataset containing 540 runs and 90 encoded input features was preprocessed using out-of-fold residual screening, after which several nonlinear regressors were compared using both log-transformed and raw endpoint targets. Repeated cross-validation selected a raw-target XGBoost model, XGB_raw, as the final endpoint surrogate, with RMSE [Formula: see text]. The independent hold-out subset favored histogram-based gradient boosting models, indicating that the leading boosting-based models were closely matched. For XGB_raw, hold-out performance improved after residual screening from RMSE [Formula: see text], MAE [Formula: see text], and [Formula: see text] to RMSE [Formula: see text], MAE [Formula: see text], and [Formula: see text]. Feature-attribution analysis identified hemicellulose content, substrate concentration, temperature, residence time, enzyme-assisted pretreatment, pH, cellulose content, and mixing rate as important endpoint predictors. The selected endpoint surrogate was then coupled to a three-phase hybrid simulator representing enzyme production, hydrolysis, and fermentation. Endpoint-guided calibration identified biologically plausible parameterizations that reproduced the target endpoint through moderate changes in growth, enzyme production, hydrolytic capacity, and product formation. Because independent time-resolved CBP trajectories were unavailable, the simulated profiles are interpreted as endpoint-constrained reconstructions rather than validated kinetic trajectories. A synthetic unscented Kalman filter study showed accurate reconstruction of sugar and scaled-product states, with lower-fidelity recovery of enzyme dynamics. Overall, the framework provides a feasibility-oriented basis for CBP endpoint prediction, mechanistic interpretation, and preliminary soft-sensing design under sparse-data conditions.

Indexed as

Consolidated bioprocessingEndpoint-guided hybrid modelingGrey-box modelingSoft sensingUnscented Kalman filter

Identifiers

PMID42472721
PMCPMC13381484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.